The downregulation of IL7R in T-ALL/T-LBL might cause a rise in tyrosine kinase activity inside the leukemia cells, leading to continuous stimulation of cytokine receptor signaling pathways and ultimately culminating in significant impairments in T-cell function (61, 62). This evidence concerns the gene IL7R and leukemia.